Machine-Learning-Enhanced Non-Invasive Testing for MASLD Fibrosis: Shallow-Deep Neural Networks Versus FIB-4, Tabular Foundation Models, and Large Language Models
Athanasios Angelakis, Gabriele De Vito, Eleni-Myrto Trifylli, and Filomena Ferrucci

TL;DR
This study evaluates machine-learning models, including shallow-deep neural networks and foundation models, to improve non-invasive detection of advanced liver fibrosis in MASLD patients, outperforming traditional FIB-4 scores.
Contribution
It introduces a compact neural network that enhances fibrosis detection accuracy while maintaining the same clinical variable space as FIB-4.
Findings
s-DNN outperformed FIB-4 in external cohorts
s-DNN achieved higher ROC-AUC scores than other models
Calibration showed s-DNN had better Brier scores
Abstract
Advanced fibrosis is a major determinant of liver-related morbidity in metabolic dysfunction-associated steatotic liver disease (MASLD). FIB-4 is widely used as a first-line non-invasive test, but its fixed formula may underuse diagnostic information contained in age, aspartate aminotransferase, alanine aminotransferase, and platelet count. We evaluated whether machine-learning-enhanced non-invasive testing (MLE-NIT) can improve advanced fibrosis detection while preserving this FIB-4 variable space. We used three biopsy-confirmed MASLD cohorts from China, Malaysia, and India (n=784). The Chinese cohort was split into 486 training and 54 internal validation/tuning patients; final performance was reported only on the Malaysian and Indian external cohorts. Models used five variables: age, FIB-4, aspartate aminotransferase, platelet count, and alanine aminotransferase. We compared FIB-4…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
